View Post

Concurrent Chemoradiotherapy Better for Painful Bone Metastases in Breast Cancer

In In The News by Barbara Jacoby

By: Colby Strong From: cancertherapyadvisor.com Concurrent chemoradiotherapy is tolerable and reduces pain better than radiotherapy alone for patients with breast cancer and painful bone metastases, according to research published in the Journal of Bone Oncology. The randomized, phase 2 study included 84 patients with breast cancer and painful bone metastases. The patients were randomly assigned to radiotherapy only (42 patients) …

View Post

Perlmutter Cancer Center Radiation Oncologist Works to Minimize Side Effects of Radiation

In In The News by Barbara Jacoby

Source: nyulangone.org As a radiation oncologist, Naamit K. Gerber, MD, associate professor in the Department of Radiation Oncology at NYU Grossman School of Medicine, provides the latest and most advanced treatments to people who have breast cancer and lymphoma. Dr. Gerber is co-director of the Breast Cancer and Hematologic Malignancies Disease Management Groups at NYU Langone Health’s Perlmutter Cancer Center, …

View Post

Metabolic memory plays a key role in breast cancer relapse

In In The News by Barbara Jacoby

Source: EMBO From: sciencedaily.com Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumour cells that proved resistant to the original treatment. Recent advances in early detection and targeted therapy have led to a growing success in treating breast cancer upon first presentation. This often …

View Post

Chemo Creates Leaky Blood Vessels Helping Cancer Cells To Spread

In In The News by Barbara Jacoby

From: technologynetworks.com A new study adds to the evidence that chemotherapy enhances cancer’s spread beyond the primary tumor, showing how one chemo drug allows breast cancer cells to squeeze through and attach to blood vessel linings in the lungs. The research in mice leaves no doubt that the chemo drug caused changes to non-cancer cells that enable this process. Scientists …

View Post

Erica Mayer, MD, on Updated HER2- Breast Cancer Guidelines

In In The News by Barbara Jacoby

By: Jeff Minerd From: medpagetoday.com New ASCO recommendations highlight genomic profiling and novel agents ASCO has published two sets of updated guidelines for patients with human epidermal growth factor receptor 2 (HER2) negative breast cancer, both in the Journal of Clinical Oncology. One of the updates (Burstein et al.) covers endocrine treatment and targeted therapy for patients with hormone receptor …

View Post

FDA’s New Guidance for Breast Implants: What Breast Cancer Patients Need to Know

In In The News by Barbara Jacoby

From: mskcc.org The US Food and Drug Administration (FDA) announced on October 27, 2021, new safety requirements for breast implants. The agency placed a “black box” warning on all breast implants to inform patients of the potential risks, including Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), and other symptoms that some patients with breast implants have experienced, including fatigue, joint …

View Post

Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts

In In The News by Barbara Jacoby

From: PR Newswire The addition of the NCI expands the Caris POA network of leading oncology experts and institutions focused on precision medicine Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today that the Caris Precision Oncology Alliance™ (POA) and NCI’s Center for Cancer Research (CCR) will collaborate on precision medicine research initiatives. The …

View Post

Gilead, Merck to study combination therapy for breast cancer

In In The News by Barbara Jacoby

By: PBR Staff Writer From: pharmaceutical-business-review.com Gilead Sciences and Merck have signed an agreement to assess the efficacy of Trodelvy (sacituzumab govitecan-hziy) in combination with Keytruda (pembrolizumab) to treat patients with metastatic triple-negative breast cancer (TNBC). Gilead Sciences and Merck have signed an agreement to assess the efficacy of Trodelvy (sacituzumab govitecan-hziy) in combination with Keytruda (pembrolizumab) to treat patients …

View Post

Providers are requesting fewer preoperative MRIs for breast cancer patients

In In The News by Barbara Jacoby

By: Hannah Murphy From: healthimaging.com Providers are requesting fewer preoperative MRI exams for breast cancer patients, but a new analysis suggests more can be done to align with evidence-based guidelines. In 2016 the American Society of Breast Surgeons published “Choosing Wisely,” which opposed the preoperative use of MRI in breast cancer patients. The document cited multiple concerns with the practice—increased need for …